Authors

Dr. Levinson, Department of Ophthalmology, Division of JSEI Treatment Centers, Ocular Inflammatory Disease Center, UCLA Comprehensive Ophthalmology Division, Los Angeles, CA.

Ramón Ruiz-Mesa, MD

Ramin Khoramnia, MD

Ramin Tadayoni, MD, PhD

Tadayoni is professor of ophthalmology at Université de Paris in France and head of department at Lariboisière, Saint Louis and Adolphe de Rothschild Foundation hospitals.

He is a European Society of Retina Specialists board member, past president of the French-speaking Retina Specialists and the leader of RHU EviRed, a national artificial intelligence project on diabetic retinopathy supported by the French government.

Tadayoni is a consultant to Zeiss, Alcon, Bausch + Lomb, Moria, Allergan, Bayer, Novartis, Roche-Genentech, Thea and Oculis.

Ranjan P. Malhotra, MD, FACS

Ranya Habash, MD

Habash is the medical director of Technology innovation at the Bascom Palmer EyE Institute.

Raymond James

Rebekah Bernard, MD

Reena A. Garg, MD

Refractive Surgery Council